Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: December 2, 2016

Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks

Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular “off” switch for the inflammatory immune response that contributes to lung-constricting asthma attacks. The switch, they say, is composed of regulatory proteins that control an immune signaling pathway in cells.

Released: December 1, 2016

Flu season has begun, but Johns Hopkins experts say the peak of the season is yet to come

Flu cases are being reported in Maryland and across the country, and experts at the Johns Hopkins University School of Medicine expect to see numbers continue to rise. To prevent the flu, Johns Hopkins experts say everyone 6 months and older should get vaccinated against the influenza virus every year.

Released: December 1, 2016

Expansion Augments Oncology Services Previously Available at Sibley and Suburban hospitals

Cancer experts from the Johns Hopkins Kimmel Cancer Center are now embedded in a newly expanded facility within Johns Hopkins Medicine-owned Sibley Memorial Hospital in northwest Washington, D.C.

Released: December 1, 2016

Researchers analyzed over 3 million suicide attempt-related emergency department visits between 2006 and 2013

Johns Hopkins investigators report that their analysis of a national database representing more than 1 billion emergency department visits shows that over a recent eight-year period, nothing much has changed in the rates of unsuccessful suicide attempts, or in the age, gender, seasonal timing or means used by those who tried to take their lives in the United States.

Released: December 1, 2016

In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin — the active compound in hallucinogenic “magic mushrooms.”

Released: November 30, 2016

Since the discovery of the fossil dubbed Lucy 42 years ago this month, paleontologists have debated whether the 3 million-year-old human ancestor spent all of her time walking on the ground or instead combined walking with frequent tree climbing. Now, analysis of special CT scans by scientists from The Johns Hopkins University and the University of Texas at Austin suggests the female hominin spent enough time in the trees that evidence of this behavior is preserved in the internal structure of her bones. A description of the research study appears November 30 in the journal PLOS ONE.

Released: November 30, 2016

Technique shows promise in increasing accuracy of prostate and breast cancer treatment in people

An international group of researchers report success in mice of a method of using positron emission tomography (PET) scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer. This androgen receptor pathway drives development and progression of the vast majority of prostate cancers. The technique shows promise, the investigators say, as a novel way to use such an antibody to detect and monitor prostate and other hormone-sensitive cancers, as well as to guide therapy in real time.

Released: November 29, 2016

In a small study of young or recently retired NFL players, researchers at Johns Hopkins report finding evidence of brain injury and repair that is visible on imaging from the players compared to a control group of men without a history of concussion.

Released: November 28, 2016

Hair loss and breakage can be remedied with proper cleansing and styling practices

A common cause of hair loss and breakage known as acquired trichorrhexis nodosa, or TN —often more prevalent in African-Americans — can actually be remedied through appropriate use of cleansing products, hair care and styling practices, say researchers at Johns Hopkins.

Released: November 28, 2016

To “turn off” particular regions of genes or protect them from damage, DNA strands can wrap around small proteins, called histones, keeping out all but the most specialized molecular machinery. Now, new research shows how an enzyme called KDM4B “reads” one and “erases” another so-called epigenetic mark on a single histone protein during the generation of sex cells in mice. The researchers say the finding may one day shed light on some cases of infertility and cancer.   

Released: November 21, 2016

Four Johns Hopkins University researchers have been elected by their peers as fellows of the American Association for the Advancement of Science (AAAS).

Released: November 18, 2016

Graduated from the Johns Hopkins School of Medicine in 1944

Pioneering heart surgeon Denton A. Cooley, a 1944 graduate of the Johns Hopkins School of Medicine who participated in the birth of cardiac surgery at Hopkins as a young intern and went on to become one of the greatest heart surgeons of the 20th century, died today in Houston, Texas. He was 96.

Released: November 17, 2016

Diabetes affects about one in 11 Americans, and 40 percent of adults who have the disease don’t know it. Diabetes occurs when your body does not properly process food as energy — it either doesn’t respond to the hormone insulin or doesn’t produce any at all. If left untreated, the disease can lead to major health problems. Our experts can provide insight on diabetes, how to care for it and where research is headed.

Released: November 17, 2016

Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy

Johns Hopkins Medicine specialists report they have developed a urine test for the likely emergence of cervical cancer that is highly accurate compared to other tests based on genetic markers derived directly from cervical tissue.

Released: November 16, 2016

Research may advance understanding of cancer spread and wound healing

Living cells respond to biochemical signals by moving toward those at higher concentration, a process carefully mapped out by biologists over the past several decades. But cells also move in response to mechanical forces, such as bumping up against other objects — although the details of that action have been poorly understood. Now, results of a new study, published Nov. 7 in the journal PNAS, reveal that cells use the same network of molecules to react to both chemical and mechanical signals, allowing them to combine potentially conflicting signals into a unified path.

Released: November 15, 2016

The Johns Hopkins University (JHU) School of Medicine and Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) have extended their collaboration in translational research, which started in 2015, to include a joint postdoctoral fellowship training program.

Released: November 10, 2016

A new five-year collaboration between The Johns Hopkins University and Bristol-Myers Squibb aims to answer why some patients respond to immunotherapy drugs called checkpoint blockers and some do not, and to develop more effective combination immunotherapies. Projects included in the collaboration will span laboratory research on patients’ tumor samples and several early-stage clinical trials led by Johns Hopkins scientists at the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Released: November 10, 2016

New drug cures tuberculosis infections in mice

Researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls.

Released: November 8, 2016

Johns Hopkins University received a $10 million grant from the Steven and Alexandra Cohen Foundation to explore Lyme disease and develop potential new therapies to address the illness. Johns Hopkins is the only institution in the nation to receive multiple Lyme disease grants from the foundation.

Released: November 8, 2016

Preclinical tests show novel molecule called RK-33 stops cell proliferation and makes cells more sensitive to radiation

An experimental drug that targets abnormally high levels of a protein linked to cancer growth appears to significantly reduce the proliferation of prostate cancer cells in laboratory cell cultures and animals, while also making these cells considerably more vulnerable to radiation, according to results of a study led by Johns Hopkins scientists.